Camilla Thellenberg Karlsson

Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial

Ian F. Tannock, Karim Fizazi, Camilla Thellenberg Karlsson et al. · The Lancet Oncology · 2013 · 287 citations

Medicine, Oncology, Pharmacology +16

Haralick texture features from apparent diffusion coefficient (ADC) MRI images depend on imaging and pre-processing parameters

Patrik Brynolfsson, David Nilsson, Turid Torheim et al. · Scientific Reports · 2017 · 165 citations · Full text

Medicine, Radiology, Biomedical Imaging +16

U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden

Bengt Glimelius, Beatrice Melin, Gunilla Enblad et al. · Acta Oncologica · 2017 · 102 citations · Full text

Medicine, Oncology, Pathology +16

Breast Cancer as a Second Primary in Patients With Prostate Cancer—Estrogen Treatment or Association With Family History of Cancer?

Camilla Thellenberg Karlsson, Beatrice Malmer, Fredrik Wiklund et al. · The Journal of Urology · 2006 · 36 citations

Medicine, Endocrinology, Oncology +13

Re-treatment with radium-223: first experience from an international, open-label, phase I/II study in patients with castration-resistant prostate cancer and bone metastases

Oliver Sartor, Daniel Heinrich, Neil Mariados et al. · Annals of Oncology · 2017 · 33 citations · Full text

Medicine, Oncology, Pharmacotherapy +17